This is not a moment our community can afford to spend fighting itself,” writes American Diabetes Association CEO Charles ...

Novartis and Bristol Myers Squibb have paused multiple cell therapy trials, while $480,000 has now become a routine price for ...

The whole of my field has been flattened into a single lazy question: Did the health care system fail her?” writes Jennifer ...

An NIH proposal to cap the number of research grants investigators can receive has drawn a mixed reception, the agency says.

Shihipar directs narrative projects and policy impact initiatives at the People, Place, and Health Collective at the Brown ...

The federal spending bill has an important provision for researchers, and Trump announced more MFN deals with pharma firms.

More Trump drug pricing deals, GSK speeds up development of mRNA flu vaccine, and other biotech news ...

A review of findings from a five-person committee is being sent to the ADA board for action, STAT has learned, but it appears unlikely to quiet the controversy.

Here are some of the key questions about the agreements the Trump administration has reached with drugmakers on pricing.

The House voted to pass a stopgap funding bill that, for now, blocks a White House proposal to give political appointees more ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. You’re reading the web edition of ...

With clinical success on a personalized mRNA vaccine for melanoma, experts are hoping for a more stable future for the ...